Current Heart Failure Reports

, Volume 5, Issue 1, pp 51–55

Future directions in cardiac resynchronization therapy

Article

Abstract

Cardiac resynchronization therapy (CRT) reduces symptoms and improves mortality in patients with moderate to severe chronic heart failure (New York Heart Association class III–IV) in sinus rhythm with reduced left ventricular ejection fraction and with wide QRS on the surface electrocardiogram as evidence of ventricular dyssynchrony. CRT’s benefit in patients with atrial fibrillation, mild heart failure, or a conventional indication for antibradycardia pacing is being assessed. Moreover, the PROSPECT trial assessed whether the response rate to CRT might increase if, in addition to wide QRS, mechanical dyssynchrony criteria were required. The RethinQ study examined whether patients with narrow QRS but with mechanical dyssynchrony benefit from CRT. Finally, whether patients with heart failure with preserved left ventricular function also may benefit from CRT remains to be studied.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Recommended Reading

  1. 1.
    Cazeau S, Leclercq C, Lavergne T, et al.: Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 2001, 344:873–880.PubMedCrossRefGoogle Scholar
  2. 2.
    Abraham WT, Fisher WG, Smith AL, et al.: Cardiac resynchronization in chronic heart failure. N Engl J Med 2002, 346:1845–1853.PubMedCrossRefGoogle Scholar
  3. 3.
    Young JB, Abraham WT, Smith AL, et al.: Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD trial. JAMA 2003, 289:2685–2694.PubMedCrossRefGoogle Scholar
  4. 4.
    Bristow MR, Saxon LA, Boehmer J, et al.: Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004, 350:2140–2150.PubMedCrossRefGoogle Scholar
  5. 5.
    Cleland JG, Daubert JC, Erdmann E, et al.: The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005, 352:1539–1549.PubMedCrossRefGoogle Scholar
  6. 6.
    Leclercq C, Kass DA: Retiming the failing heart: principles and current clinical status of cardiac resynchronization. J Am Coll Cardiol 2002, 39:194–201.PubMedCrossRefGoogle Scholar
  7. 7.
    Shen AY, Wang X, Doris J, Moore N: Proportion of patients in a congestive heart failure care management program meeting criteria for cardiac resynchronization therapy. Am J Cardiol 2004, 94:673–676.PubMedCrossRefGoogle Scholar
  8. 8.
    Vardas PE, Auricchio A, Blanc JJ, et al.: Guidelines for cardiac pacing and cardiac resynchronization therapy: the task force for cardiac pacing and cardiac resynchronization therapy of the European Society of Cardiology. Developed in collaboration with the European Heart Rhythm Association. Eur Heart J 2007, 28:2256–2295.PubMedCrossRefGoogle Scholar
  9. 9.
    Yu CM, Chan YS, Zhang Q, et al.: Benefits of cardiac resynchronization therapy for heart failure patients with narrow QRS complexes and coexisting systolic asynchrony by echocardiography. J Am Coll Cardiol 2006, 48:2251–2257.PubMedCrossRefGoogle Scholar
  10. 10.
    Bleeker G, Holman ER, Steendijk P, et al.: Cardiac resynchronization therapy in patients with a narrow QRS complex. J Am Coll Cardiol 2006, 48:2243–2250.PubMedCrossRefGoogle Scholar
  11. 11.
    Beshai JF, Grimm RA, Nagueh SF, et al.: Cardiac-resynchronization therapy in heart failure with narrow QRS complexes. N Engl J Med 2007, 357:2461–2471.PubMedCrossRefGoogle Scholar
  12. 12.
    Bax JJ, Bleeker GB, Marwick TH, et al.: Left ventricular dyssynchrony predicts response and prognosis after cardiac resynchronization therapy. J Am Coll Cardiol 2004, 44:1834–1840.PubMedCrossRefGoogle Scholar
  13. 13.
    Pitzalis MV, Iacoviello M, Romito R, et al.: Cardiac resynchronization therapy tailored by echocardiographic evaluation of ventricular asynchrony. J Am Coll Cardiol 2002, 40:1615–1622.PubMedCrossRefGoogle Scholar
  14. 14.
    Yu CM, Abraham WT, Bax JJ, et al.: Predictors of response to cardiac resynchronization therapy (PROSPECT)—study design. Am Heart J 2005, 149:600–605.PubMedCrossRefGoogle Scholar
  15. 15.
    Ghio S, Chung E, Abraham WT, et al.: Predictors of response to cardiac resynchronization therapy (PROSPECT) study. Circulation 2008, In press.Google Scholar
  16. 16.
    St John Sutton MG, Plappert T, Abraham WT, et al.: Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure. Circulation 2003, 107:1985–1990.PubMedCrossRefGoogle Scholar
  17. 17.
    Higgins SL, Hummel JD, Niazi IK, et al.: Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias. J Am Coll Cardiol 2003, 42:1454–1459.PubMedCrossRefGoogle Scholar
  18. 18.
    Abraham WT, Young JB, Leon AR, et al.: Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter-defibrillator, and mildly symptomatic chronic heart failure. Circulation 2004, 110:2864–2868.PubMedCrossRefGoogle Scholar
  19. 19.
    Bleeker GB, Schalij MJ, Holman ER, et al.: Cardiac resynchronization therapy in patients with systolic left ventricular dysfunction and symptoms of mild heart failure secondary to ischemic or nonischemic cardiomyopathy. Am J Cardiol 2006, 98:230–235.PubMedCrossRefGoogle Scholar
  20. 20.
    Swedberg K, Cleland J, Dargie H, et al.: Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J 2005, 26:1115–1140.PubMedCrossRefGoogle Scholar
  21. 21.
    Hunt SA, Abraham WT, Chin MH, et al.: ACC/AHA guidelines update on the diagnosis and management of chronic heart failure in the adult. J Am Coll Cardiol 2005, 46:1179–1207.CrossRefGoogle Scholar
  22. 22.
    Linde C, Gold M, Abraham WT, Daubert JC: Rationale and design of a randomized controlled trial to assess the safety and efficacy of cardiac resynchronization therapy in patients with asymptomatic left ventricular dysfunction with previous symptoms or mild heart failure—the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study. Am Heart J 2006, 151:288–294.PubMedCrossRefGoogle Scholar
  23. 23.
    Konstam MA, Udelson JE, Anand IS, et al.: Ventricular remodeling in heart failure: a credible surrogate endpoint. J Card Fail 2003, 9:350–353.PubMedCrossRefGoogle Scholar
  24. 24.
    Carson P, Tognoni G, Cohn JN: Effect of valsartan on hospitalization: results from the Val-HeFT. J Card Fail 2003, 9:164–171.PubMedCrossRefGoogle Scholar
  25. 25.
    Wong M, Staszewsky L, Latini R, et al.: Severity of left ventricular remodeling defines outcomes and response to therapy in heart failure: Valsartan heart failure trial (Val-HeFT) echocardiographic data. J Am Coll Cardiol 2004, 43:2022–2027.PubMedCrossRefGoogle Scholar
  26. 26.
    Linde C, Gold M, Abraham WT, Daubert JC: Baseline characteristics of patients randomized in Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction (REVERSE) study. Congest Heart Fail 2008, In press.Google Scholar
  27. 27.
    Moss A, Brown MW, Cannom DS, et al.: Multicenter automatic defibrillator implantation trial-cardiac resynchronization therapy (MADIT-CRT): design and clinical protocol. Ann Noninvasive Electrocardiol 2005, 10(4 Suppl):34–43.PubMedCrossRefGoogle Scholar
  28. 28.
    Leclercq C, Walker S, Linde C, et al.: Comparative effects of permanent biventricular and right univentricular pacing in heart failure patients with chronic atrial fibrillation. Eur Heart J 2002, 23:1780–1787.PubMedCrossRefGoogle Scholar
  29. 29.
    Linde C, Leclercq C, Rex S, et al.: Long-term benefits of biventricular pacing in congestive heart failure: results from the MUltisite STimulation in cardiomyopathy (MUSTIC) study. J Am Coll Cardiol 2002, 40:111–118.PubMedCrossRefGoogle Scholar
  30. 30.
    Leon AR, Greenberg JM, Kanuru N, et al.: Cardiac resynchronization in patients with congestive heart failure and chronic atrial fibrillation: effect of upgrading to biventricular pacing after chronic right ventricular pacing. J Am Coll Cardiol 2002, 39:1258–1263.PubMedCrossRefGoogle Scholar
  31. 31.
    Gasparini M, Auricchio A, Regoli F, et al.: Four-year efficacy of cardiac resynchronization therapy on exercise tolerance and disease progression: the importance of performing atrioventricular junction ablation in patients with atrial fibrillation. J Am Coll Cardiol 2006, 48:734–743.PubMedCrossRefGoogle Scholar
  32. 32.
    Gasparini M, Auricchio A, Lamp B, et al.: Four-year survival in 1285 patients undergoing cardiac resynchronization therapy (CRT). The importance of atrioventricular junction ablation in patients with atrial fibrillation [abstract]. Eur Heart J 2006, 27(Suppl):25.Google Scholar
  33. 33.
    Yu CM, Fang F, Zhang Q, et al.: Improvement of atrial function and atrial reverse remodeling after cardiac resynchronization therapy for heart failure. J Am Coll Cardiol 2007, 50:778–785.PubMedCrossRefGoogle Scholar
  34. 34.
    Hoppe U, Casares JM, Eiskjaer H, et al.: Effect of cardiac resynchronization on the incidence of atrial fibrillation in patients with severe heart failure. Circulation 2006, 114:18–25.PubMedCrossRefGoogle Scholar
  35. 35.
    Barold SS: Adverse effects of ventricular desynchronization induced by long-term right ventricular pacing. J Am Coll Cardiol 2003, 42:624–626.PubMedCrossRefGoogle Scholar
  36. 36.
    Baldasseroni S, Opasich C, Goroni M, et al.: Left bundle branch block is associated with increased 1-year sudden and total mortality rate in 5517 patients with congestive heart failure: a report from the Italian network on congestive heart failure. Am Heart J 2002, 143:398–405.PubMedCrossRefGoogle Scholar
  37. 37.
    Funck RC, Blanc JJ, Mueller HH, et al.: Biventricular stimulation to prevent cardiac desynchronization: rationale, design, and endpoints of the ‘Biventricular Pacing for Atrioventricular Block to Prevent Cardiac Desynchronization (BioPace)’ study. Europace 2006, 8:629–635.PubMedCrossRefGoogle Scholar
  38. 38.
    Lenzen MJ, Scholte op Reimer WJ, Boersma E, et al.: Differences between patients with a preserved and a depressed left ventricular function: a report from the EuroHeart Failure Survey. Eur Heart J 2004, 25:1214–1220.PubMedCrossRefGoogle Scholar
  39. 39.
    Bursi F, Weston SA, Redfield MM, et al.: Systolic and diastolic heart failure in the community. JAMA 2006, 296:2209–2216.PubMedCrossRefGoogle Scholar
  40. 40.
    Owan TE, Hodge DO, Herges RM, et al.: Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 2006, 355:251–259.PubMedCrossRefGoogle Scholar
  41. 41.
    Bhatia RS, Tu JV, Lee DS, et al.: Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med 2006, 355:260–269.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  1. 1.Department of CardiologyKarolinska University HospitalSolnaSweden

Personalised recommendations